Company Filing History:
2 out of 766 
2 out of 5 
2 out of 13 
Years Active: 2024-2025
Title: Jaume Pons: Innovator in Antibody Research
Introduction
Jaume Pons is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of antibody research, holding a total of 4 patents. His work focuses on developing innovative therapies for cancer treatment and understanding the mechanisms of immune response.
Latest Patents
Among his latest patents is a groundbreaking invention related to antibodies against signal-regulatory protein alpha. This patent provides isolated antibodies that bind to specific extracellular domains of human SIRP-α polypeptides. These antibodies have the potential to block or reduce binding interactions with human CD47 polypeptides, which is crucial for cancer treatment. Another notable patent involves combination therapies that utilize a hypomethylation agent for treating hematological cancers, such as myelodysplastic syndrome. This method combines a specific polypeptide with a hypomethylating agent, showcasing his innovative approach to cancer therapy.
Career Highlights
Jaume Pons has worked with esteemed organizations, including the University of Tennessee Research Foundation and Attralus, Inc. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Throughout his career, Pons has collaborated with notable colleagues, including Jonathan Wall and Hong Wan. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Jaume Pons is a distinguished inventor whose work in antibody research is paving the way for new cancer therapies. His innovative patents and collaborations highlight his commitment to advancing medical science.